Open access · CC-BY
via OpenAlex
Editorial: Proteostasis in cardiac health and disease
Hannah Bühringer, Shirin Doroudgar, Xuejun Wang, Norbert Frey, Ashraf Yusuf Rangrez
Frontiers in Molecular Biosciences · 2024 · ▲ 9 citations
Loss of proteostasis
Altered intercellular communication
Disabled macroautophagy
Partial reprogramming (OSK)
Cell culture / in vitro
Rat
Human
Mouse
In vitro
Review
Abstract
However, the detailed insights provided in this review and the results of a recent study by Wu et al. give rise to the possibility of USP-13 involvement in cardiac diseases (8). Recent evidence suggests that the cytoskeleton of cardiomyocytes is crucial for maintaining balanced communica�on between the various components of the proteostasis(definition) network (2). One of the cri�cal components of the cytoskeleton is the intermediate filament protein, desmin. Gene�c varia�ons and loss of desmin cause desminopathies, including desmin-related cardiomyopathies. The review by Su et al. discusses the role of desmin impairment as a trigger for cardiac arrythmias and the underlying molecular mechanisms. A derailment of PQC with the forma�on of aberrant protein aggregates can have dras�c effects in cardiac diseases (1,2). Petersen et al. discovered Fibin, fin bud ini�a�on factor homolog, as a novel protein induced in cardiac hypertrophy. In vitro, using neonatal rat ventricular cardiomyocytes, they found Fibin to act as a regulator of cardiomyocyte hypertrophy through inhibi�on of SRF and NFAT signaling, two well described pathways involved in cardiomyocyte hypertrophy. In the expecta�on of a posi�ve effect on cardiac hypertrophy, they next inves�gated the role of Fibin in vivo, using a cardiomyocyte restricted Fibin overexpression mouse model. Surprisingly however, these transgenic mice developed dilated cardiomyopathy and cardiac dysfunc�on in aging, pressure-overload, and calcineurin mouse models. The cause of this unexpected phenotype was iden�fied as the result of a proteostasis perturba�on leading to aberrant protein aggrega�on, increased ER stress and the Uncoupled Protein Response (UPR), resul�ng in UPR-mediated apoptosis. Thus, this study demonstrates the importance of balanced proteostasis and exemplifies the poten�ally devasta�ng effects of dysregulated proteostasis on the heart. Overall, these studies demonstrate the importance and complexity of cardiac proteostasis. While research into cardiac proteostasis is s�ll in its infancy, protein homeostasis has been implicated in the context of aging. As we age, proteoly�c ac�vity declines resul�ng in the accumula�on of damaged proteins and aggregates, which are causal in the onset of several chronic diseases (9). Best characterized are the effects of toxic accumula�ons in the age-related neurodegenera�ve diseases, Parkinson's, Alzheimer's, and Hun�ngton's Disease (10). However, more and more evidence suggest that a decline in PQC may be causal for the development of other widespread diseases, including obesity and type 2 diabetes (9)(10)(11). The health burden caused by the aforemen�oned diseases requires mul�disciplinary studies to elucidate a possible link between the derailment of proteostasis in different diseases. One intriguing possibility is the idea of trea�ng mul�ple diseases by therapeu�cally improving proteasome func�on (3). One poten�al, rela�vely recent approach is the ac�va�on of the proteasome by small molecules (12). Even though several promising possible targets and compounds are emerging, the consequences and side effects of chronic exposure to proteasome enhancers are not yet known. However, in the future, therapeu�cally targe�ng proteostasis could open completely new possibili�es in the treatment of widespread diseases, including CVDs.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fmolb.2024.1433721
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
Bühringer, H., Doroudgar, S., Wang, X., Frey, N., & Rangrez, A.Y. (2024). Editorial: Proteostasis in cardiac health and disease. <em>Frontiers in Molecular Biosciences</em>. https://doi.org/10.3389/fmolb.2024.1433721
Vancouver
Bühringer H, Doroudgar S, Wang X, Frey N, Rangrez AY. Editorial: Proteostasis in cardiac health and disease. Frontiers in Molecular Biosciences. 2024. doi:10.3389/fmolb.2024.1433721.
BibTeX
@article{hannah2024Editor,
title = {Editorial: Proteostasis in cardiac health and disease},
author = {Hannah Bühringer and Shirin Doroudgar and Xuejun Wang and Norbert Frey and Ashraf Yusuf Rangrez},
journal = {Frontiers in Molecular Biosciences},
year = {2024},
doi = {10.3389/fmolb.2024.1433721},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Neuroscience 2019
Open access · CC-BY
Dysfunction of Cellular Proteostasis in Parkinson’s Disease
Mediators of Inflammation 2018
Open access · CC-BY
Anti-Inflamm-Ageing and/or Anti-Age-Related Disease Emerging Treatments: A Historical Alchemy or Revolutionary Effective Procedures?
Journal of Cachexia Sarcopenia and Muscle 2021
Open access · CC-BY
Age‐related decline in murine heart and skeletal muscle performance is attenuated by reduced Ahnak1 expression
Annual Review of Biochemistry 2009
Citation only
Biological and Chemical Approaches to Diseases of Proteostasis Deficiency
Innovation in Aging 2024
Open access · CC-BY
MAPPING LONGEVITY PATHWAYS THROUGH MITOCHONDRIAL DYSFUNCTION: ROLES OF THE MICROBIOME AND METABOLISM IN AGING
Frontiers in Cell and Developmental Biology 2022
Open access · CC-BY